Skip to main content
Top

Diabetes Therapy

Issue 11/2023

Content (14 Articles)

Open Access Hypoglycemia Review

Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia

Marga Giménez, Kamlesh Khunti, Munehide Matsuhisa, Suresh Chenji, Kristen Syring, Yu Yan

Open Access Metformin Review

Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes

Luis Alberto Vázquez, Irene Romera, Miriam Rubio-de Santos, Javier Escalada

Open Access Insulins Review

Optimising Insulin Injection Techniques to Improve Diabetes Outcomes

Sanjay Kalra, Faruque Pathan, Ida Ayu Made Kshanti, Nguyen Quang Bay, Terumasa Nagase, Teresa Oliveria, Shailendra Bajpai

Open Access Insulin Glargine Original Research

Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme

Kristina S. Boye, Vivian Thuyanh Thieu, Hélène Sapin, Clare J. Lee, Laura Fernández Landó, Katelyn Brown, Ross Bray, Russell J. Wiese, Hiren Patel, Ángel Rodríguez, Maria Yu

Open Access Heart Failure Original Research

Treatment with SGLT2 Inhibitors in Patients with Diabetes Mellitus and Extensive Coronary Artery Disease: Mortality and Cardiovascular Outcomes

David Chipayo-Gonzales, Asad Shabbir, Carlos Vergara-Uzcategui, Luis Nombela-Franco, Pilar Jimenez-Quevedo, Nieves Gonzalo, Ivan Nuñez-Gil, Hernan Mejia-Renteria, Fernando Macaya-Ten, Gabriela Tirado-Conte, Maria Jose Perez-Vizcayno, Manuel Fuentes, Javier Escaned, Antonio Fernandez-Ortiz, Pablo Salinas

Open Access Tirzepatide Original Research

Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide

Kristina S. Boye, Hélène Sapin, Wenxiu Dong, Suzanne Williamson, Clare J. Lee, Vivian Thuyanh Thieu

Open Access Liraglutide Original Research

Efficacy and Safety of a Biosimilar Liraglutide (Melitide®) Versus the Reference Liraglutide (Victoza®) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial

Alireza Esteghamati, Mehran Zamanzadeh, Mojtaba Malek, Mohammad Khaledi, Arezoo Monavari, Laily Najafi, Zahra Banazadeh, Ramin Malboosbaf, Rokhsareh Aghili, Sedigheh Mahdikhah, Hasan Ganjizadeh-Zavereh, Hamidreza Kafi, Farhad Hosseinpanah, Mohammad Ebrahim Khamseh

Open Access Bronchial Asthma Original Research

A Longitudinal Clinical Trajectory Analysis Examining the Accumulation of Co-morbidity in People with Type 2 Diabetes (T2D) Compared with Non-T2D Individuals

Adrian Heald, Rui Qin, Richard Williams, John Warner-Levy, Ram Prakash Narayanan, Israel Fernandez, Yonghong Peng, J. Martin Gibson, Kevin McCay, Simon G. Anderson, William Ollier

Open Access Insulins Original Research

Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

Maryana Savytska, Dmytro Kyriienko, Iuliia Komisarenko, Oleksandr Kovalchuk, Tetyana Falalyeyeva, Nazarii Kobyliak

Open Access Insulins Original Research

Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes

Richard M. Bergenstal, Bruce W. Bode, Anuj Bhargava, Qianqian Wang, Alastair W. Knights, Annette M. Chang

Open Access Dulaglutid Original Research

Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study

Meredith Hoog, Rosirene Paczkowski, Ahong Huang, Rachel Halpern, Erin Buysman, Sydnie Stackland, Yiran Zhang, Ruth Wangia-Dixon

Open Access Albuminuria Correction

Correction to: Prevalence of Diabetic Kidney Disease with Different Subtypes in Hospitalized Patients with Diabetes and Correlation Between eGFR and LncRNA XIST Expression in PBMCs

Yingbei Lin, Peili Wu, Lei Guo, Qijian Feng, Ling Wang, Xiaochun Lin, Chuyi Yang, Nannan Liu, Churan Wen, Xuelin Li, Xiaoqin Ma, Yaoming Xue, Meiping Guan

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.